Replies to post #362752 on Amarin Corp Plc (AMRN)

[dukesking]

Ralphy, I bought more at $4.40, and even more at $3.52, and $3.40. Good luck. There’s a reason AMRN has met soooo much resistance and that Hikma and Reddy are all in on IPE full steam ahead, Nissen is unrelenting and ran his own O3 trial, ambulance chasers have initiated frivolous lawsuits, BP are still developing competing CVD drugs, others are still developing O3 prescription meds, and patents are under attack. They don’t want AMRN to have it all to themselves. Add to that that Pfizer is now involved in Canada, China’s coming on board this month, BB still holds a large position and Dr Denner has come on board. They all see the huge potential of high dose purified and proven IPE for CVD and other potential indications. IMHO.

[oneragman]

ralphey, the price is definitely dirt cheap, but so are most growth stocks. Stocks where I have visibility into the future via management with definite plans that include time tables. KM has a plan for sure and has laid out some of the time frame, but until a real plan to deal with generics is in place for the US and we start to see growth in revenues, there is really no reason to invest more here.

[Number sleven]

Ralphey, I started buying this week. I will continue to add when possible.
Sleven,